Skip to main content
Year archive

Luye Pharma Group Limited — 2024 filings

All 87 regulatory filings released by Luye Pharma Group Limited (2186) in 2024, sourced directly from the official regulator.

87 Filings
2024 Period
2024 filings (87)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
Director's Dealing
2024-12-18 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement
2024-12-17 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement
2024-12-17 English
Interim Report 2024
Interim / Quarterly Report H1 2024
2024-12-17 English
OVERSEAS REGULATORY ANNOUNCEMENT
Capital/Financing Update
2024-12-16 English
COMPLETION OF THE ISSUE OF US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2024-12-13 English
CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN BERMUDA
Regulatory Filings
2024-12-09 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-12-04 English
VOLUNTARY ANNOUNCEMENT APPROVAL OF ZEPZELCA (LURBINECTEDIN FOR INJECTION) FOR MARKETING IN MAINLAND CHINA
Regulatory Filings
2024-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings
2024-12-02 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Interim / Quarterly Report H1 2024
2024-11-29 English
CHANGE OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2024-11-29 English
VOLUNTARY ANNOUNCEMENT - RUOXINLIN AND OTHER DRUGS INCLUDED ON CHINA'S 2024 NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2024-11-28 English
PROFIT WARNING
Regulatory Filings
2024-11-22 English
NOTICE OF BOARD MEETING
Regulatory Filings
2024-11-20 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA
Regulatory Filings
2024-11-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-11-04 English
OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2024-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings
2024-11-01 English
COMPLETION OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Regulatory Filings
2024-10-30 English
CHANGE OF CLOSING DATE OF THE ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Regulatory Filings
2024-10-28 English
PROPOSED ISSUE OF US$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025 AND US$50,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Regulatory Filings
2024-10-23 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-10-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
Regulatory Filings
2024-10-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-10-02 English
Interim Report 2024
Regulatory Filings
2024-09-29 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-09-05 English
CHANGE OF COMPANY NAME AND STOCK SHORT NAME
Regulatory Filings
2024-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
Regulatory Filings
2024-09-04 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Regulatory Filings
2024-08-28 English
NOTICE OF BOARD MEETING
Regulatory Filings
2024-08-15 English
DISCLOSEABLE TRANSACTION - THIRD PARTY INVESTMENT IN SHENZHEN LUYE - COMPLETION OF THE INITIAL INVESTMENT
Regulatory Filings
2024-08-12 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 9 AUGUST 2024
Regulatory Filings
2024-08-09 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIALS FOR Innovative Dual TAAR1/5-HT2CR Agonist (LY03020)
Regulatory Filings
2024-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings
2024-08-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-08-02 English
VOLUNTARY ANNOUNCEMENT - ERZOFRI (PALIPERIDONE PALMITATE) EXTENDED-RELEASE INJECTABLE SUSPENSION APPROVED BY THE FDA FOR TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
Regulatory Filings
2024-07-28 English
DISCLOSEABLE TRANSACTION THIRD PARTY INVESTMENT IN SHENZHEN LUYE
Regulatory Filings
2024-07-23 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023/24
Regulatory Filings
2024-07-10 English
Annual Report 2023/24
Regulatory Filings
2024-07-10 English
Notification Letter and Request Form to Non-registered Shareholders
Regulatory Filings
2024-07-10 English
Notification Letter and Reply Form to Registered Shareholders
Regulatory Filings
2024-07-10 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on 9 August 2024 at 10:00 a.m.
Regulatory Filings
2024-07-10 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2024-07-10 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; RE-APPOINTMENT OF INDEPENDENT AUDITOR&#x3b; PROPOSED CHANGE OF COMPANY NAME&#x3b; AND NOTICE OF ANNUAL GENER
Regulatory Filings
2024-07-10 English
PROPOSED CHANGE OF COMPANY NAME
Regulatory Filings
2024-07-10 English
VOLUNTARY ANNOUNCEMENT - MIMEIXIN (OXYCODONE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE SUSTAINED-RELEASE TABLETS) APPROVED FOR MARKETING IN CHINA
Regulatory Filings
2024-07-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings
2024-07-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-07-02 English
VOLUNTARY ANNOUNCEMENT - THE MANUFACTURING FACILITY OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) HAS PASSED PAI BY U.S. FDA WITH NO FDA-483
Regulatory Filings
2024-06-27 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-06-27 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2024
Regulatory Filings
2024-06-24 English
VOLUNTARY ANNOUNCEMENT - JINYOUPING (ROTIGOTINE MICROSPHERES FOR INJECTION) APPROVED FOR MARKETING IN CHINA
Regulatory Filings
2024-06-20 English
PROFIT WARNING
Regulatory Filings
2024-06-19 English
VOLUNTARY ANNOUNCEMENT - MEIBIRUI (PALIPERIDONE PALMITATE INJECTION) APPROVED FOR MARKETING IN CHINA
Regulatory Filings
2024-06-11 English
VOLUNTARY ANNOUNCEMENT - NDA FILED FOR RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH IN JAPAN
Regulatory Filings
2024-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Regulatory Filings
2024-06-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-05-31 English
DATE OF BOARD MEETING
Regulatory Filings
2024-05-31 English
Notification Letter and Request Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2024-05-28 English
Altered Memorandum of Association and Bye-laws
Regulatory Filings
2024-05-28 English
Notification Letter and Request Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2024-05-28 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2024
Regulatory Filings
2024-05-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings
2024-05-06 English
SUPPLEMENTAL ANNOUNCEMENT - APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS AND INDEPENDENT NON-EXECUTIVE DIRECTORS
Regulatory Filings
2024-05-03 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024
Regulatory Filings
2024-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2024-04-29 English
Annual Report 2023
Regulatory Filings
2024-04-29 English
Environmental, Social and Governance Report 2023
Regulatory Filings
2024-04-29 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTORS WHO HAVE SERVED MORE THAN NINE YEARS OF THE COM
Regulatory Filings
2024-04-29 English
List of Directors and their Roles and Functions
Regulatory Filings
2024-04-29 English
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS AND INDEPENDENT NON-EXECUTIVE DIRECTORS
Regulatory Filings
2024-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Regulatory Filings
2024-04-08 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-04-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Regulatory Filings
2024-03-27 English
NOTICE OF BOARD MEETING
Regulatory Filings
2024-03-14 English
APPOINTMENT OF AUDITOR
Regulatory Filings
2024-03-11 English
CHANGE OF AUDITOR
Regulatory Filings
2024-03-08 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP'S INNOVATIVE FORMULATION LY01610
Regulatory Filings
2024-03-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Regulatory Filings
2024-03-01 English
VOLUNTARY ANNOUNCEMENT - UPDATED PROGRESS IN RELATION TO THE MARKETING REVIEW OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) IN THE UNITED STATES
Regulatory Filings
2024-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings
2024-02-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-02-01 English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
Regulatory Filings
2024-01-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings
2024-01-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-01-02 English